Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-11 09:10 am Purchase | 2020-12-31 | 13G | Arena Pharmaceuticals, Inc. ARNA | Wellington Management Group LLP | 6,289,051 10.810% | 1,613,188 (+34.50%) | Filing History |
| 2021-01-11 09:10 am Sale | 2020-12-31 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ | Wellington Management Group LLP | 1,567,656 5.340% | -2,324,600 (-59.72%) | Filing History |
| 2021-01-11 09:10 am Purchase | 2020-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN | Wellington Management Group LLP | 234,772 10.600% | 234,772 (New Position) | Filing History |
| 2021-01-11 09:10 am Purchase | 2020-12-31 | 13G | Mimecast Limited MIME | Wellington Management Group LLP | 6,575,477 10.290% | 3,271,912 (+99.04%) | Filing History |
| 2021-01-11 09:10 am Purchase | 2020-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Wellington Management Group LLP | 157,104 10.300% | 157,104 (New Position) | Filing History |
| 2021-01-11 09:10 am Sale | 2020-12-31 | 13G | SVMK INC SVMK | Wellington Management Group LLP | 7,941,442 5.580% | -6,352,587 (-44.44%) | Filing History |
| 2021-01-11 09:10 am Purchase | 2020-12-31 | 13G | TCR2 Therapeutics Inc. TCRR | Wellington Management Group LLP | 3,753,364 11.230% | 3,753,364 (New Position) | Filing History |